PRM is an active participant in solutions that ensure that cancer patients receive optimal care. Pharma becomes an even greater ally to our network of physicians when they have access to patient outcomes, feedback on toxicities of oral medications and recommended clinical pathways.
Analytics are the key driver in the navigation of best-practice evidence-based medicine. PRM is committed to developing programs that bring mutually beneficial outcomes to our pharma partners and our member physicians. We believe this is essential to the continued development of the most comprehensive sharing of data that can positively impact the future of drug development and best practice models.